(Q34630274)

English

Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: does the addition of systemic bevacizumab improve results?

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: does the addition of systemic bevacizumab improve results? (English)

1 reference

Europe PubMed Central

3 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

object named as

Mithat Gönen

0 references

7

object named as

Yuman Fong

1 reference

Europe PubMed Central

3 August 2017

10

object named as

Peter Allen

1 reference

Europe PubMed Central

3 August 2017

author name string

Nancy E Kemeny

1

1 reference

Europe PubMed Central

3 August 2017

Lawrence Schwartz

2

1 reference

Europe PubMed Central

3 August 2017

Mithat Gönen

3

1 reference

Europe PubMed Central

3 August 2017

Adam Yopp

4

1 reference

Europe PubMed Central

3 August 2017

David Gultekin

5

1 reference

Europe PubMed Central

3 August 2017

Michael I D'Angelica

6

1 reference

Europe PubMed Central

3 August 2017

Dana Haviland

8

1 reference

Europe PubMed Central

3 August 2017

Alexandra N Gewirtz

9

1 reference

Europe PubMed Central

3 August 2017

William R Jarnagin

11

1 reference

Europe PubMed Central

3 August 2017

publication date

14 June 2011

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

80

1 reference

Europe PubMed Central

3 August 2017

3-4

1 reference

Europe PubMed Central

3 August 2017

153-159

1 reference

Europe PubMed Central

3 August 2017

Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123741

7 July 2018

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123741

7 July 2018

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123741

7 July 2018

Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123741

7 July 2018

Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123741

7 July 2018

Indications for neoadjuvant, adjuvant, and palliative chemotherapy in the treatment of biliary tract cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123741

7 July 2018

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123741

7 July 2018

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123741

7 July 2018

Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123741

7 July 2018

Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123741

7 July 2018

Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123741

7 July 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123741

7 July 2018

Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123741

7 July 2018

An analysis of 412 cases of hepatocellular carcinoma at a Western center

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123741

7 July 2018

Regional chemotherapy approaches for primary and metastatic liver tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123741

7 July 2018

Hepatic artery pump infusion: toxicity and results in patients with metastatic colorectal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123741

7 July 2018

Hepatic perfusion with FUdR utilizing an implantable system in patients with liver primary cancer or metastatic cancer confined to the liver

1 reference

https://api.crossref.org/works/10.1159%2F000324704

21 January 2018

Downstaging of hepatocellular carcinoma and liver metastases from colorectal cancer by selective intra-arterial chemotherapy

1 reference

https://api.crossref.org/works/10.1159%2F000324704

21 January 2018

Role of adjuvant therapy after resection of colorectal cancer liver metastases

1 reference

https://api.crossref.org/works/10.1159%2F000324704

21 January 2018

Hepatic arterial infusion after liver resection

1 reference

https://api.crossref.org/works/10.1159%2F000324704

21 January 2018

Nasal Septum Perforation in a Bevacizumab-Treated Patient with Metastatic Breast Cancer

1 reference

https://api.crossref.org/works/10.1159%2F000324704

21 January 2018

Surgery after downstaging of unresectable hepatic tumors with intra-arterial chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21677464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatic artery infusion of 5-fluorouracil and mitomycin C in cholangiocarcinoma and gallbladder carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21677464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump

1 reference

https://pubmed.ncbi.nlm.nih.gov/21677464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rising incidence of hepatocellular carcinoma in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/21677464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths

1 reference

https://pubmed.ncbi.nlm.nih.gov/21677464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumab.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21677464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1159/000324704

1 reference

Europe PubMed Central

3 August 2017

PMC publication ID

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34630274&oldid=1980208835"